Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades.

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

New information may help speed development of a vaccine or treatment for dengue fever.

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.